To test this, they synthesized glutathione (GSH)-responsive GSDMD protein cages that were designed to be released preferentially in the GSH-rich tumor cells and tethered the cages to an attenuated Salmonella typhimurium (VNP) strain (VNP-GD). The gene discussed is GSDMD; the disease is neoplasm.